Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
81.77
-0.06 (-0.07%)
At close: Dec 5, 2025, 4:00 PM EST
81.76
-0.01 (-0.01%)
After-hours: Dec 5, 2025, 6:05 PM EST

Tarsus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
3,4712,117670391465840
Upgrade
Market Cap Growth
93.65%215.74%71.44%-15.95%-44.60%-
Upgrade
Enterprise Value
3,1521,873455185283857
Upgrade
Last Close Price
81.7755.3720.2514.6622.5041.33
Upgrade
PS Ratio
9.1011.5738.4215.158.16-
Upgrade
PB Ratio
10.369.433.402.032.795.06
Upgrade
P/TBV Ratio
10.609.793.472.032.795.06
Upgrade
P/FCF Ratio
----147.13-
Upgrade
P/OCF Ratio
----124.13-
Upgrade
EV/Sales Ratio
8.6110.2426.107.154.96-
Upgrade
EV/FCF Ratio
----89.41-
Upgrade
Debt / Equity Ratio
0.250.320.150.100.010.01
Upgrade
Debt / FCF Ratio
----0.38-
Upgrade
Asset Turnover
0.800.570.070.130.33-
Upgrade
Inventory Turnover
26.2923.12----
Upgrade
Quick Ratio
4.074.216.6414.3014.9831.21
Upgrade
Current Ratio
4.294.436.9314.6115.3331.68
Upgrade
Return on Equity (ROE)
-28.35%-54.83%-69.71%-34.53%-8.31%-24.01%
Upgrade
Return on Assets (ROA)
-12.00%-23.46%-36.27%-19.27%-4.33%-14.65%
Upgrade
Return on Capital (ROIC)
-15.00%-28.75%-40.65%-20.58%-4.54%-15.04%
Upgrade
Return on Capital Employed (ROCE)
-20.90%-40.70%-62.60%-29.50%-7.30%-16.20%
Upgrade
Earnings Yield
-2.34%-5.46%-20.27%-15.88%-2.97%-3.19%
Upgrade
FCF Yield
-1.66%-4.00%-17.75%-12.67%0.68%-2.57%
Upgrade
Buyback Yield / Dilution
-12.21%-27.98%-19.35%-19.78%-231.12%-162.72%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.